| Neuroradiology A Journal Devoted to Neuroimaging and Interventional Neuroradiology |
| © The Author(s) 2008 |
| 10.1007/s00234-008-0470-y |
Steffi F. Dreha-Kulaczewski1
, Gunther Helms2, Peter Dechent2, Sabine Hofer3, 4, Jutta Gärtner1 and Jens Frahm3
| (1) | Department of Pediatrics and Pediatric Neurology, Georg August University, Robert-Koch-Str. 40, 37075 Göttingen, Germany |
| (2) | MR-Research in Neurology and Psychiatry, Georg August University, Göttingen, Germany |
| (3) | Biomedizinische NMR Forschungs GmbH am Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany |
| (4) | Bernstein Center for Computational Neuroscience, Göttingen, Germany |
![]() |
Steffi F. Dreha-Kulaczewski Email: sdreha@gwdg.de |
Received: 4 June 2008 Accepted: 7 October 2008 Published online: 29 October 2008
Keywords Balo’s concentric sclerosis - Childhood - Magnetic resonance spectroscopy - Diffusion tensor imaging - tNAA recovery
Balo’s concentric sclerosis (BC) is a demyelinating disorder and considered a rare variant of multiple sclerosis (MS) [1]. Pathognomonic MRI features include large concentric ring-like or whorled-appearing lesions in white matter (WM) with alternating hyper- and hypointense bands on T2-weighted images with, if active, multiple consecutively enhancing and non-enhancing layers on contrast-enhanced T1-weighted MRI [2]. Neuropathologically, the lesion is characterized by alternating circular lamellae of well preserved and demyelinated WM [3]. Several hypotheses have been brought forward to explain this conspicuous pattern. The myelinated bands have either been considered areas of remyelination that develop between successive episodes of active demyelination [4] or early stages of demyelination [5]. Moore et al. [6] postulated a lesion to start as a confluent area of demyelination which spreads centrifugally, becomes downregulated and blazes up again at the periphery. Immunopathological studies suggested a resemblance to hypoxic tissue injuries as Stadelmann et al. [7] reported signs of neuroprotection at the edge of actively demyelinating bands possibly including oligodendrocytes that are resistant to further damage hence leading to the concentric preservation.
So far, proton magnetic resonance spectroscopy (MRS) studies of BC have only been performed in adult patients [2, 8, 9], including follow-up measurements over up to 23 months [10-13]. More recently, diffusion tensor imaging (DTI) has been applied [11, 13–15]. However the MRI findings of a 4-year-old boy by Murakami et al. [16] seem to be the only study from the pediatric patient population. Here, we report a combined follow-up MRS and DTI study over almost 6 years of a child diagnosed with BC. The study was carried out to better elucidate underlying biochemical and microstructural alterations depicted by the different MR-methods and their correlations with the evolution of clinical symptoms.
The previously healthy 13.8-year-old girl was admitted at another hospital with an acute right homonym hemianopsia, increasing sleepiness, anomia, and perturbed consciousness following a febrile upper respiratory tract infection. Despite several therapeutic trials (dexamethason, aciclovir, rocephin intravenous and predison per os) the clinical condition worsened. MRI examinations within the first month after onset of symptoms showed a small lesion in left frontal WM with contrast enhancement, another small lesion within right frontal WM, and a most prominent lesion with widespread edema in the left hemisphere involving parietal, temporal, and occipital lobe and demonstrating a temporary cockade-like contrast enhancement.
Seven months later, a first relapse occurred with a complex-partial seizure, abulia, and hypokinesia with subsequent remittance. MRI of the brain showed a new contrast-enhancing, concentric lesion in the right frontal premotor region. The known LPO WM lesion appeared smaller. Foscarnet and methylprednisolone were administered intravenously. A maintenance therapy with immunoglobulin (2 g/kg intravenous) was added for 8 months.
The second relapse occurred 3.4 years after the onset with a left hemiparesis, which was again treated with intravenous methylprednisolone. A new concentric lesion was identified within the right suprathalamic region. On T1-weighted images, the LPO WM lesion had transformed to a hypointense, chronic lesion. The remission has so far been incomplete leaving the patient with a left spastic hemiparesis. She now receives an immunomodulatory therapy with α-interferon. Follow-up MRI did not show any new lesion but a considerable atrophy in the LPO WM region.
A total of seven localized proton MRS studies were performed 1, 2, and 4 months as well as 3.4, 3.8, 4.8, and 5.8 years after the onset of symptoms. The institutional review board approved the study and the parents gave informed consent before each examination. The first three studies were conducted at 2 T (Magnetom Vision; Siemens Medical Solutions, Erlangen, Germany), the latter four at 3 T (Magnetom Trio). Proton MR spectra (64 accumulations) were acquired with use of a STEAM localization sequence with repetition time (TR)/echo time (TE)/mixing time (TM) = 6000/20/10 ms as described [18, 19]. The 4.85 ml (2 T) and 4.1 ml (3 T) volume-of-interest (VOI) was placed within the LPO WM covering the structural lesion but excluding the perifocal edema if possible (indicated in Fig. 1b). For the last MRS examination the VOI was reduced to 2.7 ml to account for tissue loss. Absolute concentrations of N-acetylaspartate and N-acetylaspartylglutamate (tNAA), creatine and phosphocreatine (tCr), choline-containing compounds (Cho), myo-inositol (Ins), and lactate (Lac) were determined by LCModel fitting a linear combination of model spectra [20] and compared to age-matched controls (n = 14) taken from Pouwels et al. [21].
To allow for adequate fiber tractography, DTI in the 6th examination was performed at 2.2 mm isotropic resolution (38 contiguous slices, 3 averages). Estimates of axonal projections were computed by the fiber assignment by continuous tracking (FACT) algorithm using software developed in-house [24, 25]. Tracking terminated when the FA value was lower than 0.15 or the main diffusion directions in consecutive steps differed by more than 40° (empirically optimized thresholds). The geniculo-calcarine tracts were determined by region-to-region tracking using regions-of-interest (ROIs) defined on color-coded maps of the main diffusion direction. In order to study secondary degenerative effects of the corpus callosum (CC), the surface of the CC was reconstructed. To compare CC abnormalities of the patient with an age-matched control, a recently developed CC scheme was applied to delineate the fiber topography of the CC by separating transcallosal projections into prefrontal, premotor (and supplementary motor), primary motor, primary sensory, parietal, temporal, and occipital regions [26].
|
Time after onset (age) |
1 mo (13.8) |
2 mos (13.9) |
4 mos (14.1) |
3.4 yrs (17.1) |
3.8 yrs (17.4) |
4.8 yrs (18.4) |
5.8 yrs (19.4) |
Controls |
|---|---|---|---|---|---|---|---|---|
|
tNAA |
1.7a |
2.8a |
3.8a |
5.0a |
5.2a |
5.6a |
5.4a |
7.9 ± 0.5 |
|
tCr |
3.6a |
4.1 |
5.4 |
4.9 |
5.0 |
5.2 |
4.1 |
4.7 ± 0.5 |
|
Cho |
2.3a |
3.0a |
2.5a |
2.2a |
1.7 |
1.6 |
1.4 |
1.6 ± 0.2 |
|
Ins |
2.5 |
6.8a |
8.0a |
8.0a |
6.4a |
6.1a |
5.3 |
3.9 ± 1.1 |
|
Lac |
8.0 |
4.1 |
4.1 |
1.5 |
1.4 |
<1 |
<1 |
<1 |
The acute phase was characterized by a reduction of most metabolite concentrations in conjunction with a pronounced elevation of Lac. In more detail, the tNAA concentration was significantly reduced yielding only 22% of control values. In the intermediate phase, the tNAA level partially recovered and after another 3 to 4 years reached a constant level of about 70% of control values. The concentration of tCr was acutely decreased to 77% of control values but regained normal levels within 3 months. The Cho concentration was elevated up to 188% of control values in the acute and intermediate phase, but gradually declined to normal concentrations after 3 to 4 years. The reduced Ins concentration in the acute phase (64% of control values) was followed by a rapid increase to 174 and 205% of control values in the intermediate phase. This high Ins level was maintained for up to 4 years before slowly decreasing toward normal values (136% at 5.8 years). The acutely elevated Lac concentration of 8 mmol/l (control < 1 mmol/l) decreased to 4.1 mmol/l during the intermediate phase and subsequently over more than 4 years to below detectability.
|
Time after onset (age) |
1 mo (13.8) |
2 mos (13.9) |
4 mos (14.1) |
3.4 yrs (17.1) |
3.8 yrs (17.4) |
4.8 yrs (18.4) |
5.8 yrs (19.4) |
Controls |
|---|---|---|---|---|---|---|---|---|
|
FA |
0.11a |
0.18a |
0.14a |
0.12a |
0.11a |
0.07a |
0.08a |
0.44 ± 0.08 |
|
MD |
1.1a |
1.06a |
1.29a |
1.68a |
1.58a |
1.69a |
1.74a |
0.76 ± 0.05 |
The combined neurochemical and microstructural alterations observed here for a typical BC lesion in vivo are in close agreement with previous findings from histopathological assessments [3–7]. The temporal evolution of the metabolic disturbances is indicative of initial neuroaxonal damage and active demyelination which are followed by partial recovery and gliotic processes. The persistently reduced diffusion anisotropy and enhanced water mobility reflect a permanent damage to the tissue structure. These latter findings refer to the neuroaxonal connectivity in both the lesioned area disrupting the optic radiation unilaterally and the premotor and motor regions of the corpus callosum.
The initial metabolite pattern of the LPO WM lesion with strikingly reduced tNAA and high Cho and Lac concentrations is in line with active demyelination. Almost identical metabolic disturbances have frequently been reported for demyelinating processes in conjunction with various leukodystrophies, for example in children with adrenoleukodystrophy [27]. In this context, the tNAA reduction may be taken as a sign of neuroaxonal damage. This is because tNAA has been shown to be predominantly localized within neurons and axons and validated as an axon-specific marker of cerebral WM [28–30]. Complementary, the MRS-detectable Cho resonance comprises precursor molecules for membrane synthesis as well as the corresponding degradation products and therefore relates to structural integrity [31]. The initial high and for almost 3 years elevated Cho concentration may be attributed to ongoing active demyelination and breakdown of myelin phospholipids. However, increased membrane turnover has also been associated with inflammatory cellular infiltration which is known to occur in BC and therefore a likely contributor to a high Cho level [7, 32]. The subsequent gradual decrease of Cho probably reflects the cessation of active demyelinating processes which are usually replaced by reactive astrocytosis and gliosis. In fact, the course of the Ins concentration, which has been found in high concentrations in astrocytes [33], is in excellent agreement with this histopathological observation.
The Lac concentration was strongly increased 1 month after disease onset and slowly disappeared over time. In general, this finding may indicate non-oxidative glycolysis during ischemia/hypoxia or disturbances in the respiratory chain. Although active BC lesions resemble aspects found in early hypoxic/ischemic WM as well as in active pattern III MS lesions [7], these are not satisfactory explanations for our patient. Instead, Lac production may be preferentially due to the activation of macrophages and their non-oxidative glucose utilization, which have been found in abundance in BC lesions [6, 34]. The observation of mobile lipids in lesions of adult patients with BC [8, 10] could not be confirmed in our study of a child despite the use of short-echo time proton MRS.
A most remarkable finding of this study is the substantial recovery of tNAA during disease progression. The synthesis of NAA from l-aspartate and acetyl-CoA catalyzed by N-acetyl-transferase takes place in the neuronal mitochondria. A translocase transports it into the cytosolic compartment from where it travels the axons via active axonal transport. As NAA cannot be hydrolyzed in these cells, the molecule participates in an intercompartmental cycle between neurons and oligodendrocytes where it is catabolized by aspartoacylase. It has been postulated that NAA turnover is conducted via molecular water pumps and that it plays a major role in brain osmoregulation [35]. Furthermore, NAA has been suggested to act as a precursor for the neurotransmitter NAAG, as an acetyl donor during myelination, and as a molecule participating in interneuronal and intercellular signaling [35, 36].
According to the aforementioned functions, several factors may contribute to the reversible reduction of tNAA. Firstly, edema, as a prominent feature of the acute lesion, may simply reduce the relative number of axons per VOI and later reverse the effect upon absorption [32]. Secondly, owing to the osmoregulatory role of NAA, the dramatic changes in extracellular water content during the formation and resolution of the edema could directly affect the intracellular NAA concentration. In fact, in animal models without loss of neuron viability, NAA was greatly reduced or even absent presumably solely because of its function as a neuronal osmolyte [37]. Thirdly, the mitochondrial function may be reversibly impaired during inflammation in which case NAA synthesis is resumed to a significant extent at later stages [36]. Fourthly, it could be speculated that the axonal transport is re-established after subsidence of active demyelination in parallel to remyelination. The persisting reduction of tNAA to about 70% of control values can very well be attributed to the residual atrophy, that is permanent neuroaxonal loss, within the LPO WM. This explanation is not only appreciable on MRI but also supported by the structural deficits revealed by DTI.
WM diffusion anisotropy reflects the integrity of both axonal membranes and myelin sheaths. FA and MD values in our patient were significantly altered in the BC lesion and in contrast to the MRS results showed no recovery. Reduced anisotropy and increased diffusivity point to a structural damage within the delicate microarchitecture of axonal membranes, periaxonal spaces, and myelin layers which apparently remained without repair. These results are in line with data from MS patients where a range of studies document similar changes in response to a structural tissue damage, for example see Rovaris et al. [38]. Two DTI studies of adult BC reported initially reduced rather than enhanced water diffusivity in active lesions [15, 39]. The fact that we did not see such effects one month after disease onset may be due to their use of very early time points as close as day one of the disease. Almost immediate reductions of the apparent diffusion coefficient that several days later are followed by a reversal to higher values than normal are a typical observation in ischemic brain tissue after acute stroke [40].
Fiber tractography has so far not been performed in BC. It revealed a significantly impaired optic radiation in the left hemisphere almost 5 years after disease onset. The abrupt fiber truncation at the anterior border of the lesion is in full accordance with the persisting clinical symptom of right homonym hemianopsia. Neuroaxonal damage together with gliotic changes may be responsible not only for the lack of structural integrity and, hence, diffusion anisotropy, but also for impairing normal axonal transport and function. Furthermore, a surface reconstruction of the CC showed a pronounced thinning of fiber regions interconnecting right- and left-hemispheric premotor and supplementary motor areas as well as primary motor cortices [26]. In a previous study, Sydykova et al. reported a correlation between reduced FA values in the CC and a decline in fiber integrity and neurodegeneration in corresponding cortical areas [41]. Therefore, reduced FA values in CC regions covering fibers of cortical premotor and supplementary motor areas (compare Fig. 5b) fit well to the observed premotor lesions in both hemispheres.
Serial proton MRS and DTI of a child with BC revealed a coherent pattern of neurochemical and structural abnormalities and respective changes during disease progression. Metabolic disturbances were consistent with acute demyelination followed by gliosis and partial recovery of neuroaxonal metabolite concentrations. DTI resulted in persistent alterations of the microstructure not only in the MRI-detectable lesion but also in specific regions of the CC associated with motor functions.
In conclusion, proton MRS and DTI sensitively depict different processes during the evolution of a BC lesion. Whereas MRS monitors respective metabolic disturbances, DTI-based structural alterations seem to correlate better with the clinical symptoms. The combination of both methods in a clinical setting allows for a more detailed analysis of lesion development and may contribute to the establishment of prognostic criteria.
| 1. | Kastrup O, Stude P, Limmroth V (2002) Balo’s concentric sclerosis. Evolution of active demyelination demonstrated by serial
contrast-enhanced MRI. J Neurol 249:811–814 doi:10.1007/s00415-002-0718-0
|
| 2. | Karaarslan E, Altintas A, Senol U et al (2001) Balo’s concentric sclerosis: clinical and radiologic features of five cases.
AJNR Am J Neuroradiol 22:1362–1367 |
| 3. | Nandini M, Gourie-Devi M, Shankar SK et al (1993) Balo’s concentric sclerosis diagnosed intravitam on brain biopsy. Clin Neurol
Neurosurg 95:303–309 doi:10.1016/0303-8467(93)90106-Q
|
| 4. | Moore GR, Neumann PE, Suzuki K et al (1985) Balo’s concentric sclerosis: new observations on lesion development. Ann Neurol
17:604–611 doi:10.1002/ana.410170614
|
| 5. | Yao DL, Webster HD, Hudson LD et al (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions
in six patients. Ann Neurol 35:18–30 doi:10.1002/ana.410350105
|
| 6. | Moore GR, Berry K, Oger JJ et al (2001) Balo’s concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting
dinical course. Mult Scler 7:375–382 |
| 7. | Stadelmann C, Ludwin S, Tabira T et al (2005) Tissue preconditioning may explain concentric lesions in Balo’s type of multiple
sclerosis. Brain 128:979–987 doi:10.1093/brain/awh457
|
| 8. | Kim MO, Lee SA, Choi CG et al (1997) Balo’s concentric sclerosis: a clinical case study of brain MRI, biopsy, and proton magnetic
resonance spectroscopic findings. J Neurol Neurosurg Psychiatry 62:655–658 |
| 9. | Khiat A, Lesage J, Boulanger Y (2007) Quantitative MRS study of Balo’s concentric sclerosis lesions. Magn Reson Imaging 25:1112–1115
doi:10.1016/j.mri.2006.11.005
|
| 10. | Chen CJ, Chu NS, Lu CS et al (1999) Serial magnetic resonance imaging in patients with Balo’s concentric sclerosis: natural
history of lesion development. Ann Neurol 46:651–656 doi:10.1002/1531-8249(199910)46:4<651::AID-ANA15>3.0.CO;2-Y
|
| 11. | Rovira A, Pericot I, Alonso J et al (2002) Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large
demyelinating brain lesions: case report. AJNR Am J Neuroradiol 23:989–994 |
| 12. | Chen CJ (2001) Serial proton magnetic resonance spectroscopy in lesions of Balo concentric sclerosis. J Comput Assist Tomogr
25:713–718 doi:10.1097/00004728-200109000-00008
|
| 13. | Lindquist S, Bodammer N, Kaufmann J et al (2007) Histopathology and serial, multimodal magnetic resonance imaging in a multiple
sclerosis variant. Mult Scler 13:471–482 |
| 14. | Ball T, Malik O, Roncaroli F et al (2007) Apparent diffusion coefficient changes and lesion evolution in Balo’s type demyelination—correlation
with histopathology. Clin Radiol 62:498–503 doi:10.1016/j.crad.2006.11.020
|
| 15. | Kavanagh EC, Heran MK, Fenton DM et al (2006) Diffusion-weighted imaging findings in Balo concentric sclerosis. Br J Radiol
79:e28–e31 doi:10.1259/bjr/36636301
|
| 16. | Murakami Y, Matsuishi T, Shimizu T et al (1998) Balo’s concentric sclerosis in a 4-year-old Japanese infant. Brain Dev 20:250–252
doi:10.1016/S0387-7604(98)00025-4
|
| 17. | Pohl D, Rostasy K, Krone B et al (2005) Balo’s concentric sclerosis associated with primary human herpesvirus 6 infection.
J Neurol Neurosurg Psychiatry 76:1723–1725 doi:10.1136/jnnp.2004.062331
|
| 18. | Frahm J, Bruhn H, Gyngell ML et al (1989) Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial
applications to human brain in vivo. Magn Reson Med 9:79–93 doi:10.1002/mrm.1910090110
|
| 19. | Frahm J, Michaelis T, Mehrboldt KD et al (1990) Improvements in localized proton NMR spectroscopy of human brain. Water suppression,
short echo times, and 1 ml resolution. J Magn Reson 90:464–473 |
| 20. | Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679
doi:10.1002/mrm.1910300604
|
| 21. | Pouwels PJ, Brockmann K, Kruse B et al (1999) Regional age dependence of human brain metabolites from infancy to adulthood
as detected by quantitative localized proton MRS. Pediatr Res 46:474–485 doi:10.1203/00006450-199910000-00019
|
| 22. | Rieseberg S, Merboldt KD, Kuntzel M et al (2005) Diffusion tensor imaging using partial Fourier STEAM MRI with projection
onto convex subsets reconstruction. Magn Reson Med 54:486–490 doi:10.1002/mrm.20572
|
| 23. | Nolte UG, Finsterbusch J, Frahm J (2000) Rapid isotropic diffusion mapping without susceptibility artifacts. Whole brain studies
using diffusion-weighted single-shot STEAM MR imaging. Magn Reson Med 44:731–736 doi:10.1002/1522-2594(200011)44:5<731::AID-MRM11>3.0.CO;2-1
|
| 24. | Mori S, Crain BJ, Chacko VP et al (1999) Three-dimensional tracking of axonal projections in the brain by magnetic resonance
imaging. Ann Neurol 45:265–269 doi:10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3
|
| 25. | Küntzel M (2007) Parallele Datenakquisition zur Beschleunigung diffusionsgewichteter Kernspintomographie mit stimulierten Echos [Parallel data acquisition for diffusion-weighted MRI using stimulated echoes]. Dissertation, Georg-August-Universität, Göttingen. Online access University library: http://webdoc.sub.gwdg.de/diss/2007/kuentzel/kuentzel.pdf. |
| 26. | Hofer S, Frahm J (2006) Topography of the human corpus callosum revisited—comprehensive fiber tractography using diffusion
tensor magnetic resonance imaging. Neuroimage 32:989–994 doi:10.1016/j.neuroimage.2006.05.044
|
| 27. | Pouwels PJ, Kruse B, Korenke GC et al (1998) Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy.
Neuropediatrics 29:254–264 doi:10.1055/s-2007-973571
|
| 28. | Bjartmar C, Battistuta J, Terada N et al (2002) N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on
the rat optic nerve. Ann Neurol 51:51–58 doi:10.1002/ana.10052
|
| 29. | Moffett JR, Namboodiri MA, Cangro CB et al (1991) Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2:131–134 doi:10.1097/00001756-199103000-00005
|
| 30. | Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies.
Neuroscience 45:37–45 doi:10.1016/0306-4522(91)90101-S
|
| 31. | Frahm J, Hanefeld F (1996) Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 27:64–69
doi:10.1055/s-2007-973751
|
| 32. | Davie CA, Hawkins CP, Barker GJ et al (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.
Brain 117(Pt 1):49–58 doi:10.1093/brain/117.1.49
|
| 33. | Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.
Dev Neurosci 15:289–298 doi:10.1159/000111347
|
| 34. | Lopez-Villegas D, Lenkinski RE, Wehrli SL et al (1995) Lactate production by human monocytes/macrophages determined by proton
MR spectroscopy. Magn Reson Med 34:32–38 doi:10.1002/mrm.1910340107
|
| 35. | Baslow MH (2003) N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28:941–953 doi:10.1023/A:1023250721185
|
| 36. | De Stefano N, Matthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721–727 doi:10.1002/mrm.1910340511
|
| 37. | Baslow MH, Suckow RF, Gaynor K et al (2003) Brain damage results in down-regulation of N-acetylaspartate as a neuronal osmolyte. Neuromolecular Med 3:95–104 doi:10.1385/NMM:3:2:95
|
| 38. | Rovaris M, Gass A, Bammer R et al (2005) Diffusion MRI in multiple sclerosis. Neurology 65:1526–1532 doi:10.1212/01.wnl.0000184471.83948.e0
|
| 39. | Wiendl H, Weissert R, Herrlinger U et al (2005) Diffusion abnormality in Balo’s concentric sclerosis: clues for the pathogenesis.
Eur Neurol 53:42–44 doi:10.1159/000084264
|
| 40. | Lansberg MG, Thijs VN, O'Brien MW et al (2001) Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted
signal intensity of acute stroke. AJNR Am J Neuroradiol 22:637–644 |
| 41. | Sydykova D, Stahl R, Dietrich O et al (2006) Fiber Connections between the Cerebral Cortex and the Corpus Callosum in Alzheimer's
Disease: A Diffusion Tensor Imaging and Voxel-Based Morphometry Study. Cereb Cortex 17:2276–2282 |